Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Drug Safety|December 30, 2022
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World SettingHeather E Danysh, Catherine B Johannes, Daniel C Beachler, et al.
The Journal of Allergy and Clinical Immunology|January 9, 2007
Race-ethnicity, crime, and other factors associated with adherence to inhaled corticosteroidsL Keoki Williams, Christine L Joseph, Edward L Peterson, et al.
Journal of Affective Disorders|February 20, 2019
Antidepressant use in Denmark, Germany, Spain, and Sweden between 2009 and 2014: Incidence and comorbidities of antidepressant initiatorsJoan Forns, Anton Pottegård, Tammo Reinders, et al.
Nephron|February 27, 2025
Change in Urine Albumin-Creatinine Ratio and Occurrence of Hyperkalemia in Patients Initiating Finerenone in the USA: A Cohort Study from the FOUNTAIN PlatformCsaba P Kovesdy, Natalie Ebert, David Vizcaya, et al.
CNS Drugs|March 5, 2019
Risk of Acute Liver Injury in Agomelatine and Other Antidepressant Users in Four European Countries: A Cohort and Nested Case-Control Study Using Automated Health Data SourcesManel Pladevall-Vila, Anton Pottegård, Tania Schink, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 4, 2025
Outcomes in New User Cohorts of SGLT2 Inhibitors or GLP-1 Receptor Agonists with Type 2 Diabetes and Chronic Kidney DiseaseJ Bradley Layton, Ryan Ziemiecki, Catherine B Johannes, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 17, 2024
Clinical Profile and Treatment Adherence in Patients with Type 2 Diabetes and Chronic Kidney Disease Who Initiate an SGLT2 Inhibitor: A Multi-cohort StudyCatherine B Johannes, Ryan Ziemiecki, Manel Pladevall-Vila, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 19, 2025
Clinical Profile and Treatment Patterns in Individuals with Type 2 Diabetes and Chronic Kidney Disease Who Initiate a GLP-1 Receptor Agonist: A Multinational Cohort StudyManel Pladevall-Vila, Ryan Ziemiecki, Catherine B Johannes, et al.
Pageof 5